| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2 |
| 1 | ALBENDAZOLE | 1 |
| 2 | ALBUTEROL SULFATE | 1 |
| 3 | BELIMUMAB | 1 |
| 4 | CARBOPLATIN | 1 |
| 5 | DEXAMETHASONE | 1 |
| 6 | DEXAMETHASONE 1.5 MG | 1 |
| 7 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 |
| 8 | OCRELIZUMAB | 1 |
| 9 | THYROID | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBENDAZOLE | 1 | 0.0005 |
| 1 | IODIUM,BADIAGA,FUCUS VESICULOSUS,CALCAREAARSENICUM IODATUM, THYROIDINUM,CARBONICA,PULSATILLA,BARYTA CARBONICA, | 1 | 0.0004 |
| 2 | BELIMUMAB | 1 | 0.0000 |
| 3 | OCRELIZUMAB | 1 | 0.0000 |
| 4 | CARBOPLATIN | 1 | 0.0000 |
| 5 | DEXAMETHASONE 1.5 MG | 1 | 0.0000 |
| 6 | DEXAMETHASONE | 1 | 0.0000 |
| 7 | ALBUTEROL SULFATE | 1 | 0.0000 |
| 8 | ADALIMUMAB | 2 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Anthelmintic [EPC] | 1 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 1 |
| 3 | Corticosteroid [EPC] | 1 |
| 4 | Platinum-based Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 4 | Corticosteroid [EPC] | 1 | 0.0000 |